Keith Perdue, CRNA | |
225 E Jackson Ave, Jonesboro, AR 72401-3119 | |
(870) 932-4211 | |
(870) 931-9141 |
Full Name | Keith Perdue |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 21 Years |
Location | 225 E Jackson Ave, Jonesboro, Arkansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578571931 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | C01521 (Arkansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Arkansas Methodist Medical Center | Paragould, AR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Arkansas Methodist Hospital Corporation | 6608780119 | 31 |
News Archive
AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A new, multi-ethnic study found older adults with low vitamin K levels were more likely to die within 13 years compared to those whose vitamin K levels were adequate.
HHS Secretary Kathleen Sebelius today announced awards totaling $27.8 million to health center-controlled networks and large multi-site health centers to implement electronic health records (EHR) and other health information technology (HIT) innovations.
The antidepressant fluoxetine causes bone loss by instructing the brain to send out signals that increase bone breakdown, but a beta-blocker can intercept the signals, a new study in mice has found.
› Verified 7 days ago
Entity Name | Arkansas Methodist Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861593816 PECOS PAC ID: 6608780119 Enrollment ID: O20031124000746 |
News Archive
AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A new, multi-ethnic study found older adults with low vitamin K levels were more likely to die within 13 years compared to those whose vitamin K levels were adequate.
HHS Secretary Kathleen Sebelius today announced awards totaling $27.8 million to health center-controlled networks and large multi-site health centers to implement electronic health records (EHR) and other health information technology (HIT) innovations.
The antidepressant fluoxetine causes bone loss by instructing the brain to send out signals that increase bone breakdown, but a beta-blocker can intercept the signals, a new study in mice has found.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Keith Perdue, CRNA Po Box 339, Paragould, AR 72451-0339 Ph: (866) 235-2433 | Keith Perdue, CRNA 225 E Jackson Ave, Jonesboro, AR 72401-3119 Ph: (870) 932-4211 |
News Archive
AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
A new, multi-ethnic study found older adults with low vitamin K levels were more likely to die within 13 years compared to those whose vitamin K levels were adequate.
HHS Secretary Kathleen Sebelius today announced awards totaling $27.8 million to health center-controlled networks and large multi-site health centers to implement electronic health records (EHR) and other health information technology (HIT) innovations.
The antidepressant fluoxetine causes bone loss by instructing the brain to send out signals that increase bone breakdown, but a beta-blocker can intercept the signals, a new study in mice has found.
› Verified 7 days ago
Melissa Anne Cogdell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 505 E Matthews Ave Ste 303, Jonesboro, AR 72401 Phone: 870-932-4211 | |
Lauren Martin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3024 Stadium Blvd, Jonesboro, AR 72401 Phone: 501-227-0700 Fax: 501-227-0744 | |
James M Glisson, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 601 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-935-6396 Fax: 870-935-4063 | |
Mrs. Megan Renee Harrell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 225 E Washington Ave, Jonesboro, AR 72401 Phone: 870-207-4100 | |
Mr. Terry Mitchel Hughes Jr., CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 909 Enterprise Dr, Jonesboro, AR 72401 Phone: 870-336-1100 Fax: 870-336-1134 | |
Paul S Blumreich, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3024 Stadium Blvd, Jonesboro, AR 72401 Phone: 501-227-0700 Fax: 501-227-0744 | |
Edmund Carmack, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 225 E Jackson Ave, Jonesboro, AR 72401 Phone: 870-932-4211 Fax: 870-931-9141 |